Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials.

Chest - 1 May 2016

Rose Jonathan A, Cleveland Jody M, Rao Youlan, Minai Omar A, Tonelli Adriano R

Abstract excerpt

BACKGROUND: In recent years, the population of patients with pulmonary arterial hypertension (PAH) has changed dramatically, including more advanced age at diagnosis. We hypothesized that older patients have a distinct clinical profile with different disease characteristics and response to intervention. METHODS: All previously published treatment studies for PAH conducted by United Therapeutics including seven...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Antihypertensive Agents
Share to Connective Tissue Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypertension, Pulmonary

Share to Multivariate Analysis

Share to Randomized Controlled Trials as Topic

Share to Treatment Outcome

Share to Vasodilator Agents

Source

Open in PubMed Open full text

Identifiers

PMID: 26836910
DOI: 10.1016/j.chest.2015.11.008
PMCID: PMC4944788

Genes

PAH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials.PMID 26836910Read ↗

New phenotype and outcomes in connective tissue disease-associated pulmonary arterial hypertension: relevance of age-related comorbidities.Semantic proximity Read ↗

Severe pulmonary hypertension in lung disease: phenotypes and response to treatment.Semantic proximity Read ↗

Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertensionSemantic proximity Read ↗

Ethnicity in Pulmonary Arterial Hypertension: Possibilities for Novel Phenotypes in the Age of Personalized Medicine.Semantic proximity Read ↗

Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis.Semantic proximity Read ↗

Trends and Burden of Pulmonary Arterial Hypertension at Global, Regional, and National Levels from 1990 to 2021: Findings from the 2021 Global B urden of Disease StudySemantic proximity Read ↗

Changes in right heart haemodynamics and echocardiographic function in an advanced phenotype of pulmonary hypertension and right heart dysfunction associated with pulmonary fibrosis.Semantic proximity Read ↗

Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.Semantic proximity Read ↗

Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.Semantic proximity Read ↗

BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.Semantic proximity Read ↗

Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension.Semantic proximity Read ↗

Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.